Related Experiment Video
Updated: May 13, 2026
Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
[Effects of daunorubicin on KG1a cell proliferation and Eps8 expression]
Jin-Ying Gan1, Wen-Yan Xiong, Lei Wang
1Department of Hematology, Southern Medical University, Guangdong Province, China.
Abstract:
The aim of this study was to observe the inhibitory effect of daunorubicin on KG1a cells and the expression of Eps8 which is a novel tumor-associated antigen with its full name epidermal growth factor receptor pathway substrate 8 (Eps8), and to explore the effect of daunorubicin on Eps8 expression in KG1a cells at mRNA and protein levels. The KG1a cells were treated with different concentration of daunorubicin for 24, 48, 72 h, then trypan blue staining was used to detect the inhibitory rate of KGla cells, RQ-PCR and Western blot were used to detect Eps8 mRNA and Eps8 protein expression. The results showed that daunorubicin inhibited the proliferation of KG1a cells in a dose and time dependent manner (r = 0.983, P < 0.01). Daunorubicin could reduce the mRNA and protein levels of Eps8 expression in dose and time dependent manners in KG1a cells (r = 0.979, P < 0.05). It is concluded that with the increasing of concentration and time of daunorubicin acting on KG1a cells, the cell proliferative inhibitory effect increased and the expression of Eps8 decreased, suggesting that the inhibitory effect of daunorubicin on KG1a cell proliferation is realized through downregulation of Eps8 expression.
Insights
Daunorubicin effectively inhibits KG1a cell proliferation in a dose- and time-dependent manner. This anticancer effect is linked to the drug
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Context:
- KG1a cells are a human acute myeloid leukemia cell line.
- Eps8 (epidermal growth factor receptor pathway substrate 8) is a novel tumor-associated antigen.
- Daunorubicin is a commonly used chemotherapy agent.
Purpose:
- To investigate the inhibitory effect of daunorubicin on KG1a cells.
- To examine the impact of daunorubicin on Eps8 expression at both mRNA and protein levels.
- To elucidate the relationship between daunorubicin's anti-proliferative action and Eps8 expression.
Summary:
- Daunorubicin treatment significantly inhibited KG1a cell proliferation in a dose- and time-dependent manner.
- Quantitative reverse transcription PCR (RQ-PCR) and Western blot analysis revealed that daunorubicin reduced both mRNA and protein levels of Eps8.
- The reduction in Eps1 expression correlated with the increased anti-proliferative effect of daunorubicin.
Impact:
- This study suggests that daunorubicin's anti-leukemic activity may be mediated through the downregulation of Eps8 expression.
- Findings provide insights into the mechanism of action of daunorubicin in acute myeloid leukemia.
- Identifies Eps8 as a potential therapeutic target in daunorubicin-treated KG1a cells.
